- CA$7.81m
- CA$12.22m
- $18.37m
Brief: Aurora Spine Corporation Announces First Quarter Fy26 Financial Results
Aurora Spine's Q1 gross margin improves on higher direct sales
Aurora Spine Q4 revenue rises 6.8%
Aurora Spine Corp's Q3 revenue down 7.1%
Brief: Aurora Spine Corp - Launches Aurora Biologics Division
Brief: Aurora Spine Corporation Announces Fourth Quarter And Fiscal Year 2024 Financial Results
Brief: Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System
Brief: The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube Surgical Operating Tube
Brief: Aurora Spine Announces Closing Of Private Placement Financing
Brief: Aurora Spine Announces Initial Patient Enrolled For Dexa-Ctm Multicenter Study
Brief: Aurora Spine Corporation Announces Q1 Fiscal 2023 Financial Results
Brief: Aurora Spine Corporation Announces Fourth Quarter And Fiscal 2022 Financial Results
Brief: Aurora Spine Announces Presentation On Dexa Technology
Brief: Aurora Spine Receives Irb Multi-Site Selection Approval For Its Dexa-C Cervical Interbody System
Brief: Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
Brief: Aurora Spine Corporation Announces Positive Interim Results From Clinical Study Using Zip™ Mis Interspinous Fusion System
Brief: Aurora Spine Corporation Announces FDA 510(K) Clearance For Its Silo TFX™ Mis Sacroiliac Joint Fixation System
Brief: Aurora Spine Corporation Reports Q2 Financial Results
Refinitiv Newscasts - Australia’s investing giant is taking on the world